Best of the Week
Most Popular
1. US Housing Market House Prices Bull Market Trend Current State - Nadeem_Walayat
2.Gold and Silver End of Week Technical, CoT and Fundamental Status - Gary_Tanashian
3.Stock Market Dow Trend Forecast - April Update - Nadeem_Walayat
4.When Will the Stock Market’s Rally Stop? - Troy_Bombardia
5.Russia and China Intend to Drain the West of Its Gold - MoneyMetals
6.BAIDU (BIDU) - Top 10 Artificial Intelligence Stocks Investing To Profit from AI Mega-trend - Nadeem_Walayat
7.Stop Feeding the Chinese Empire - ‘Belt and Road’ Trojan Horse - Richard_Mills
8.Stock Market US China Trade War Panic! Trend Forecast May 2019 Update - Nadeem_Walayat
9.US China Trade Impasse Threatens US Lithium, Rare Earth Imports - Richard_Mills
10.How to Invest in AI Stocks to Profit from the Machine Intelligence Mega-trend - Nadeem_Walayat
Last 7 days
Silver Short-Term Trend Analysis - 26th June 19
Iran and the Dying Days Of the US Empire - 26th June 19
Why a Saturated Online Gaming Market Spells Good News for Gamblers - 26th June 19
Natural Gas Sets Up Bottom Pattern - 26th June 19
Has Gold Price Broken Out Or Not? Technicals And Fundamentals - 26th June 19
Stocks and XAU Gold Miners Next Bull and Bear Markets are Now Set Up - 26th June 19
Gold Price Trend Forcast to End September 2019 - Video - 25th June 19
Today’s Pets.com and NINJA Loan Economy - 25th June 19
Testing the Fed’s Narrative with the Fed’s Data: QT Edition - 25th June 19
What "Pro Traders" use to Find Profitable Trades - eBook - 25th June 19
GDX Gold Stocks ETF - 25th June 19
What Does Facebook’s LIBRA New Crytocurrency Really Offer? - 25th June 19
Why Bond Investors MUST Be Paying Attention to Puerto Rico - 25th June 19
The Next Great Depression in the Making - 25th June 19
The Bad News About Record-Low Unemployment - 24th June 19
Stock Market New High, but…! - 24th June 19
Formula for when the Great Stock Market Rally Ends - 24th June 19
How To Time Market Tops and Bottoms - 24th June 19
5 basic tips to help mitigate the vulnerability inherent in email communications - 24th June 19
Will Google AI Kill Us? Man vs Machine Intelligence - 24th June 19
Why are Central Banks Buying Gold and Dumping Dollars? - 23rd June 19
Financial Sector Paints A Clear Picture For Stock Market Trading Profits - 23rd June 19
What You Should Look While Choosing Online Casino - 23rd June 19
INTEL (INTC) Stock Investing to Profit From AI Machine Learning Boom - 22nd June 19
Here’s Why You Should Drive a Piece of Crap Car - 22nd June 19
How Do Stock Prices React to Fed Interest Rate Cuts? - 22nd June 19
Gold Bull Market Breaking Out! - 21st June 19
Post-FOMC Commentary: Delusions of Grandeur - 21st June 19
Gold Scores Gains as Draghi and Powel Grow Concerned - 21st June 19
Potential Upside Targets for Gold Stocks - 21st June 19
Gold Price Trend Forcast to End September 2019 - 21st June 19
The Gold (and Silver) Volcano Is Ready to Erupt - 21st June 19
Fed Leaves Rates Unchanged – Gold & Stocks Rally/Dollar Falls - 21st June 19
Silver Medium-Term Trend Analysis - 20th June 19
Gold Mining Stocks Waiting on This Chart - 20th June 19
A Key Gold Bull Market Signal - 20th June 19
Money Saving Kids Gardening Growing Giant Sunflowers Summer Fun - 20th June 19
Investing in APPLE (AAPL) to Profit From AI Machine Learning Stocks - 20th June 19
Small Cap Stocks May Lead A Market Rally - 20th June 19 -
Interest Rates Square Minus Zero - 20th June 19
Advice for Financing a Luxury Vehicle - 20th June 19
Stock Market Final Blow Off Top Just Hit… Next Week Comes the FIREWORKS - 20th June 19
US Dollar Rallies Off Support But Is This A Top Or Bottom? - 19th June 19
Most Income Investors Are Picking Up Nickels in Front of a Steamroller - 19th June 19
Is the Stock Market’s Volatility About to Spike? - 19th June 19
Facebook's Libra Crypto currency vs Bitcoin: Five Key Differences - 19th June 19
Fed May Trigger Wild Swing In Stock Index and Precious Metals - 19th June 19
How Long Do Land Rover Discovery Sport Brake Pads Last? - 19th June 19
Gold Golden 'Moment of Truth' Is Upon Us: $1,400-Plus or Not? - 18th June 19
Exceptional Times for Gold Warrant Special Attention - 18th June 19
The Stock Market Has Gone Nowhere and Volume is Low. What’s Next - 18th June 19
Silver Long-Term Trend Analysis - 18th June 19
IBM - Watson Deep Learning - AI Stocks Investing - Video - 18th June 19
Investors are Confident, Bullish and Buying Stocks, but… - 18th June 19
Gold and Silver Reversals – Impossible Not to Notice - 18th June 19

Market Oracle FREE Newsletter

Gold Price Trend Forecast Summer 2019

Don’t Be Fooled by the “Quiet Season” for Biotech Stocks

Companies / BioTech Jul 24, 2015 - 06:07 PM GMT

By: EWI

Companies

Marc Lichtenfeld writes: My favorite time to work is on weekend mornings before the rest of the house gets up.

I wake up, quietly go down the stairs and turn on the computer. While I’m waiting for it to boot up, I enjoy the peaceful scenery of the marsh outside my living room window. There are always amazing birds out there like sandhill cranes and egrets that are just a few feet from my window.


I’m not sure if it’s the stillness of the morning, the lack of distraction or what, but it’s mornings like these when I’m most productive. And when it comes to the biotech sector, summer offers the same sort of calm... not to mention major buying opportunities.

I’ll explain.

You see, the first half of the year is filled with conferences. It starts with the mother of them all, the J.P. Morgan Healthcare conference in early January. Each year I go to the conference and meet with CEOs, fund managers, analysts and investment bankers. The goal is to obtain new information that helps me lead my readers to great biotech stocks. (You can check out my write-up from this year’s event here.)

As the first half of the year goes on, there are several other conferences at which companies release key data. The American Society of Clinical Oncology Annual Meeting, for example, is the most important cancer conference of the year. It takes place in June and pretty much marks the end of the conference “season.” Tons of clinical trial data is released over a period of just a few days.

But once we hit July, the biotech newsflow typically slows down.

That doesn’t mean there is no news. Companies will still release trial results as it becomes available. But things are much quieter until late December and early January when the J.P. Morgan Conference gets started again.

This is the time of year I love. Without the flurry of activity, just like a good weekend morning, I can catch my breath... to investigate new ideas and perform due diligence on older ones that I haven’t gotten to yet.

Many investors think that because there aren’t any important conferences, you can ignore the biotech sector during the second half of the year. But staying on the sidelines can cause you to miss out on some impressive gains.

Over the past six years - since the bull market started - the Amex Biotech Index rose an average of 14.2% between July 1 and December 31. To compare, the S&P 500 rose an average of 4.7% during the same period.

Average Percent Gain Second Half of the Year 2009-2014

The second half of the year is also a good time to get positioned in stocks you want to be involved in before conference season picks up. Shares start ramping higher in the weeks before the J.P. Morgan conference in anticipation of positive announcements and a rise in the entire sector.

It’s a good idea to start getting into your stocks before everyone else does.

For example, last year I waited until August to recommend Pharmacyclics to subscribers of my biotech trading service, Lightning Trend Trader. Had I recommended it earlier, right after the J.P. Morgan Conference, investors would have paid over $130 per share. But because I waited for the excitement to die down, we were able to get in at about $120 per share.

We exited the position seven months later at $254 after Pharmacyclics agreed to be bought by AbbVie (NYSE: ABBV).

It isn’t just the niche players that can soar during summer months, either. Even some of the big boys took off in the second half of 2014. Celgene (Nasdaq: CELG) gained 29.2%, and Amgen (Nasdaq: AMGN) climbed 33.4%.

So while the summer doldrums might apply to baseball - and the market in general - biotech is a good place to put money to work while you’re snoozing at the beach.

Good investing,

Marc

Source: http://www.investmentu.com/article/detail/46718/celg-amgn-dont-be-fooled-quiet-season-in-biotech-stocks#.VbKaHU3bK0k

http://www.investmentu.com

Copyright © 1999 - 2015 by The Oxford Club, L.L.C All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Investment U, Attn: Member Services , 105 West Monument Street, Baltimore, MD 21201 Email: CustomerService@InvestmentU.com

Disclaimer: Investment U Disclaimer: Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Investment U Archive

© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules